ABOS
Price
$1.38
Change
-$0.08 (-5.48%)
Updated
Jul 29, 04:59 PM (EDT)
Capitalization
88.44M
20 days until earnings call
TCRX
Price
$1.81
Change
-$0.06 (-3.21%)
Updated
Jul 29, 04:59 PM (EDT)
Capitalization
105.82M
15 days until earnings call
Interact to see
Advertisement

ABOS vs TCRX

Header iconABOS vs TCRX Comparison
Open Charts ABOS vs TCRXBanner chart's image
Acumen Pharmaceuticals
Price$1.38
Change-$0.08 (-5.48%)
Volume$816
Capitalization88.44M
TScan Therapeutics
Price$1.81
Change-$0.06 (-3.21%)
Volume$2.08K
Capitalization105.82M
ABOS vs TCRX Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. TCRX commentary
Jul 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and TCRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 29, 2025
Stock price -- (ABOS: $1.46 vs. TCRX: $1.87)
Brand notoriety: ABOS and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 48% vs. TCRX: 101%
Market capitalization -- ABOS: $88.44M vs. TCRX: $105.82M
ABOS [@Biotechnology] is valued at $88.44M. TCRX’s [@Biotechnology] market capitalization is $105.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $316.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, TCRX is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 3 TA indicator(s) are bullish while TCRX’s TA Score has 5 bullish TA indicator(s).

  • ABOS’s TA Score: 3 bullish, 5 bearish.
  • TCRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, TCRX is a better buy in the short-term than ABOS.

Price Growth

ABOS (@Biotechnology) experienced а -5.81% price change this week, while TCRX (@Biotechnology) price change was +2.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.20%. For the same industry, the average monthly price growth was +16.79%, and the average quarterly price growth was +42.20%.

Reported Earning Dates

ABOS is expected to report earnings on Nov 17, 2025.

TCRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.20% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCRX($106M) has a higher market cap than ABOS($88.4M). ABOS YTD gains are higher at: -15.116 vs. TCRX (-38.487). ABOS has higher annual earnings (EBITDA): -111.98M vs. TCRX (-124.58M). TCRX has more cash in the bank: 252M vs. ABOS (149M). ABOS has less debt than TCRX: ABOS (29M) vs TCRX (97M). TCRX has higher revenues than ABOS: TCRX (4.42M) vs ABOS (0).
ABOSTCRXABOS / TCRX
Capitalization88.4M106M83%
EBITDA-111.98M-124.58M90%
Gain YTD-15.116-38.48739%
P/E RatioN/AN/A-
Revenue04.42M-
Total Cash149M252M59%
Total Debt29M97M30%
TECHNICAL ANALYSIS
Technical Analysis
ABOSTCRX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JUBPF0.05N/A
N/A
Jubilee Metals Group PLC
NNUP1.58N/A
N/A
Nocopi Technologies, Inc.
DFYFF56.20N/A
N/A
DEFINITY FINL CORP.
CKHGY96.86-1.14
-1.16%
Capitec Bank Holdings Ltd
DELKY20.52-0.98
-4.56%
Delek Group Ltd.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CRBU. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-7.01%
CRBU - ABOS
52%
Loosely correlated
+0.44%
BEAM - ABOS
50%
Loosely correlated
-4.10%
FHTX - ABOS
50%
Loosely correlated
+5.01%
GLSI - ABOS
50%
Loosely correlated
-0.17%
SYRE - ABOS
48%
Loosely correlated
-4.55%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with FATE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-3.11%
FATE - TCRX
44%
Loosely correlated
+4.84%
MGNX - TCRX
42%
Loosely correlated
-2.34%
ABOS - TCRX
42%
Loosely correlated
-7.01%
CRBU - TCRX
42%
Loosely correlated
+0.44%
IDYA - TCRX
40%
Loosely correlated
+2.12%
More